Breckenridge recalls propranolol capsules nationwide over possible metal contamination
One lot of 60 mg propranolol extended-release capsules shipped to U.S. pharmacies may contain metal. See the lot number, NDC and what patients should do now.

What happened
Breckenridge Pharmaceutical is recalling one lot of propranolol hydrochloride extended-release capsules, 60 mg, because the capsules may contain metal. The recall, announced Nov. 16, 2026, reaches the consumer level and covers lot PK25110035 in 100-count bottles. The company says patients with that lot should stop taking it and call their doctor for a replacement.
Key takeaways
- The capsules were shipped to wholesalers and pharmacies nationwide between Oct. 26 and Nov. 4, 2026.
- Metal pieces could cut the mouth, esophagus, stomach or intestine, according to the company. It knows of no injuries so far.
- Adare Pharma Solutions made the capsules. The suspected metal came from material shared with another lot that never reached the market.
In this article
If you fill a prescription for long-acting propranolol, take a look at the pharmacy label. Breckenridge Pharmaceutical said Monday it is recalling one lot of its propranolol hydrochloride extended-release capsules, 60 mg, because they may contain bits of metal. The bottles went out to wholesalers and pharmacies across the country in late October and early November, so some of them are likely sitting in medicine cabinets right now.
"Drug recall" showed up on Google Trends in the U.S. on Monday afternoon, with more than 1,000 searches, as local TV stations picked up the notice.
What is being recalled
The propranolol recall is narrow. It covers a single lot, according to the company's announcement, which was posted with the FDA's knowledge:
Read also: More than 4.3 million tubes of Brush Buddies, Evo and ARU toothpaste are recalled · FDA adds a blindness warning for Ozempic and all other GLP-1 drugs · White House pulls Heidi Overton's FDA nomination a day before a Senate vote
| Detail | Recalled product |
|---|---|
| Drug | Propranolol hydrochloride extended-release capsules, USP |
| Strength | 60 mg |
| Bottle | 100 capsules |
| NDC | 51991-817-01 |
| Lot number | PK25110035 |
| Expiration date | May 2029 |
| Shipped | Oct. 26 to Nov. 4, 2026, nationwide |
The capsules are white, NBC 5 Chicago reported. Adare Pharma Solutions made them for Breckenridge, a New Jersey company.
Nothing else from Breckenridge is included. Regular propranolol tablets, other strengths of the long-acting capsules, and propranolol from other drugmakers aren't part of this recall.
How to check your propranolol lot number
Pharmacies often pour capsules from the maker's 100-count bottle into their own vials, so the lot number may not be printed on your label. The quickest fix is to call the pharmacy that filled it. Pharmacists can look up which lot they dispensed to you, and they've been told to pull this one from their shelves.
If you got the original manufacturer's bottle, the lot and expiration date are on the label. You're looking for PK25110035.
Why the capsules were pulled
The trouble started with a different batch. During production, metal was found in a lot that was never released for sale. This lot shared an intermediate material with that one, which the company suspects was the source, so it is being pulled as a precaution.
The risk is physical rather than chemical. Breckenridge warned that metal fragments could cause cuts to soft tissue in the mouth, esophagus, stomach or intestine. As of Monday, the company said, it was not aware of any adverse events tied to the recall.
What to do if you take propranolol ER 60 mg
The company's instructions are direct: stop taking capsules from the recalled lot, call your doctor or other prescriber for advice and a replacement, and return any unused capsules to the pharmacy where you got them.
Make that call the same day. Propranolol is a beta blocker, and MedlinePlus warns that stopping it suddenly can bring on serious heart problems. Your doctor or pharmacist can usually get you capsules from a different lot or another maker so you don't go without.
If you think the capsules hurt you, or you notice something odd about them, tell your doctor and report it to the FDA's MedWatch program online or at 1-800-332-1088.
For questions about the recall itself, Breckenridge has hired Qualanex to handle calls at 1-855-736-0807, Monday through Friday, 9 a.m. to 5 p.m. Eastern.
What propranolol is used for
Propranolol is one of the older and more familiar heart drugs. Doctors prescribe it for high blood pressure, irregular heartbeats, chest pain from angina, certain tremors and migraine prevention, and to improve survival after a heart attack, according to MedlinePlus. The extended-release capsule is the once-a-day form. It's meant to be swallowed whole, never split, chewed or crushed.
So even one lot matters. A 100-count bottle at a pharmacy is usually split into monthly fills, which means one bottle can end up with several different patients.
A separate metoprolol recall
This is not the only blood pressure medication recall in the news this week. Advagen Pharma is pulling 3,684 bottles of metoprolol tartrate 50 mg tablets, lot 2611C065A1, after "foreign tablets/capsules" turned up in the product, the Santa Clarita Valley Signal reported. Each of those bottles holds 1,000 tablets, which is a pharmacy size.
The FDA classed the metoprolol recall as Class II and listed it in its Nov. 11 enforcement report. That notice gave no consumer instructions. For Class II and III drug recalls, the FDA says patients can generally keep taking the medicine unless told otherwise, and should ask a doctor or pharmacist if they're worried.
The two recalls have nothing to do with each other. Different companies, different drugs and different problems. NBC 5 Chicago also noted recent recalls of olmesartan-amlodipine-hydrochlorothiazide tablets and chlorthalidone tablets that didn't dissolve properly.
How this compares with other recent recalls
Drug and consumer recalls have been coming in steady waves this fall. Last month we covered the toothpaste recall, More than 4.3 million tubes of Brush Buddies, Evo and ARU toothpaste are recalled, and in food, Kayem recalls 1.58 million pounds of hot dogs, bacon and deli meat. On the safety-label side, the FDA adds a blindness warning for Ozempic and all other GLP-1 drugs.
The propranolol notice is smaller than any of those, one lot of one strength, but it's the more urgent one if it's your prescription, because the company is telling patients to stop. Check with your pharmacy before your next dose.
This article is for general information and is not medical advice. Talk to your doctor or pharmacist about your own medicine.
Frequently asked questions
- Which propranolol is being recalled?
- Only one lot of Breckenridge Pharmaceutical's propranolol hydrochloride extended-release capsules, USP, 60 mg, is recalled. It comes in 100-count bottles with NDC 51991-817-01, lot number PK25110035 and an expiration date of May 2029. Other strengths, lots and makers are not part of this recall.
- Why was propranolol recalled?
- The lot may be contaminated with metal. Breckenridge said the lot shared an intermediate material with a separate batch where metal was found; that other batch was never released. Swallowing metal fragments could cause cuts inside the mouth, throat, stomach or intestine, the company said.
- What should I do if I have recalled propranolol?
- Check the lot number on your pharmacy bottle or ask your pharmacist. If it matches PK25110035, the company says to stop taking it, call your doctor for medical advice and a replacement, and return unused capsules to the pharmacy. Call quickly, since stopping propranolol suddenly can cause heart problems.
- Is metoprolol being recalled too?
- Yes, separately. Advagen Pharma is recalling 3,684 bottles of metoprolol tartrate 50 mg tablets, lot 2611C065A1, over foreign tablets or capsules found in the product. The FDA listed it as a Class II recall in its Nov. 11 enforcement report. It is not connected to the propranolol recall.
Sources
- Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination · Breckenridge Pharmaceutical via PR Newswire, Nov. 16, 2026
- Blood pressure medication recalled nationwide over possible metal contamination · NBC 5 Chicago, Nov. 16, 2026
- Blood pressure medication recalled over 'foreign tablets' · Santa Clarita Valley Signal, Nov. 2026
- Propranolol · MedlinePlus, U.S. National Library of Medicine
- MedWatch: The FDA Safety Information and Adverse Event Reporting Program · U.S. Food and Drug Administration
About the author
Founder and editor
Marcia Reid is the founder and editor of TrendCanopy, where she reviews and edits every story.
Spotted an error? Read our corrections policy or contact us. Last reviewed November 16, 2026.
Related stories
More than 4.3 million tubes of Brush Buddies, Evo and ARU toothpaste are recalled
More than 4.3 million tubes of Brush Buddies, Evo and ARU toothpaste are in an FDA Class II recall. The full product list and what to do if you have one.
FDA adds a blindness warning for Ozempic and all other GLP-1 drugs
The FDA's new Ozempic blindness warning covers every GLP-1, from Wegovy to Zepbound. What NAION is, how rare it is, and the symptoms to watch for.
White House pulls Heidi Overton's FDA nomination a day before a Senate vote
Trump's pick to run the FDA lacked Republican votes on the Senate health committee. Why her bid stalled, who runs the agency now and what comes next.
Costco pulls Kirkland whipped cream cans in 12 states over a chemical risk
The Costco whipped cream recall covers Kirkland Signature Real Heavy Whipped Cream sold Oct. 11-31 in 12 states. How to check your can and get a refund.
Lilly's Foundayo pill cuts sleep apnea episodes by up to 44% in a trial
Lilly's GLP-1 pill Foundayo cut breathing interruptions by up to 44% in a year-long study. The FDA filing timing and how it compares to other options.
Study ties energy drinks to cardiac arrest reports in young adults
A new study ties energy drinks to cardiac arrest and heart attack reports in young adults. What the FDA data shows, its limits and how much caffeine is safe.
Trending now
News ·
House Democrats pick Hakeem Jeffries for speaker, putting him in line to make historyTech ·
GTA 6 reviews give Rockstar a 99 on Metacritic, tying Zelda's all-time recordNews ·
Florida flooding closes Broward schools after 15 inches of rain hits HollywoodEntertainment ·
Kevin Feige says Marvel was swapping Kang for Doom before Jonathan Majors was firedMoney ·
Anthropic prices its IPO at $83 a share, valuing the Claude maker at $1.5 trillion





